Fiduciary Family Office’s AbbVie ABBV Stock Holding History

Fiduciary Family Office’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.08M	Buy	14,140 +4,249	+43%	+$943K	0.88%	18
2025 Q4	$2.26M	Buy	9,891 +111	+1%	+$25.3K	0.65%	28
2025 Q3	$2.26M	Buy	9,780 +908	+10%	+$185K	0.64%	26
2025 Q2	$1.65M	Sell	8,872 -678	-7%	-$126K	0.54%	35
2025 Q1	$2M	Buy	+9,550	New	+$1.86M	0.67%	26
2024 Q4	–	Sell	-6,926	Closed	-$1.37M	–	76
2024 Q3	$1.37M	Sell	6,926 -216	-3%	-$40.3K	0.45%	45
2024 Q2	$1.22M	Sell	7,142 -2,613	-27%	-$433K	0.48%	51
2024 Q1	$1.78M	Buy	9,755 +301	+3%	+$51.9K	0.7%	33
2023 Q4	$1.47M	Buy	+9,454	New	+$1.38M	0.64%	28

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fiduciary Family Office's ABBV Position: Q1 2026 in Review

Fiduciary Family Office increased its AbbVie (ABBV) stake by 43% in Q1 2026, buying an estimated $943K and bringing the position to 14,140 shares worth $3.08M. The position accounts for 0.88% of the portfolio, ranked #18.

Fiduciary Family Office first reported a position in ABBV in Q4 2023 and has held it in 9 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Fiduciary Family Office held 14,140 shares of AbbVie worth $3.08M as of Q1 2026.
Fiduciary Family Office bought 4,249 AbbVie shares in Q1 2026, an estimated $943K.
AbbVie made up 0.88% of Fiduciary Family Office's portfolio in Q1 2026, its #18 holding.
Fiduciary Family Office first reported a position in AbbVie in Q4 2023 and has held it in 9 quarters since.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Fiduciary Family Office's 13F filing for Q1 2026, filed 14 May 2026.